Rapid Deployment: 5/21/2019 - Medical Grand Rounds: Bench to Bedside - Therapeutic Antibodies: from Horses to CARs and CAR T-cell therapy for solid tumors

Target Audience

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Describe engineered antibody domains (eAds) as candidate therapeutics.
  • Recognize the importance of the epitope for the efficacy of CAR T cell therapy.
  • Define the ideal characteristics of an antigen target for adaptive T cell therapy.
  • Identify the specific barriers for solid tumor adaptive cell therapy.
  • Recognize the potential benefits of regional delivery of CAR T cell therapy.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
08/07/2019
Course expires: 
08/07/2022
ISER
United States
Dimiter Dimitrov, PhD — Professor of Medicine, Division of Infectious Diseases, Director, Center for Antibody Therapeutics, University of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
 
Prasad Adusumilli, MD, FACS, FCCP — Deputy Chief and Attending (Tenured), Thoracic Surgery, Director, Mesothelioma Program, Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center
Dr. Adusumilli receives a potential royalty from licensing of Mesothelin CAR.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals are awarded () continuing education units (CEU) which are equivalent to contact hours.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance

Accreditation Period

Course opens: 
08/07/2019
Course expires: 
08/07/2022
Please login or register to take this course.